Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-05 · 45 (5) · 792-804
DOI: 10.1161/atvbaha.124.321916 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-05. Verfasst von Pietro Minuz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Internal Medicine C (P.M., A.M., F. Taus, M. Castelli, C.F.), University of Verona, Italy. Hauptthemen laut MEDLINE: Blood Platelets, Platelet Aggregation, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Prasugrel is converted into prasugrel active metabolite (PAM; R-138727) through the cytochrome P450–mediated conversion of an intermediate metabolite (PIM; R-95913). It is unknown whether PIM exerts any biological function. The FABOLUS-FASTER trial (Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over Prasugrel: A Multicenter Randomized Open-Label Trial in Patients With ST-Elevation Myocardial Infarction Referred for Primary Percutaneous Intervention) showed that chewed prasugrel does not improve bioactivity, in spite of accelerated PAM kinetics. METHODS: PIM and PAM pharmacokinetics were assessed by mass spectrometry in blood samples collected from ST-segment–elevation myocardial infarction patients randomized to chewed (n=17) or integral (n=15) 60 mg prasugrel. The ex vivo and in vitro effects of PAM and PIM were assessed on ADP-induced platelet activation. The binding sites of PIM and PAM were investigated by molecular dynamics simulation. RESULTS: Chewed prasugrel was associated with higher PIM levels compared with integral prasugrel: PIM median area under the curve (25–75 p): 73 (41.5–92.0) versus 33 (0.0–50.0) ng·h/mL ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of Internal Medicine C (P.M., A.M., F. Taus, M. Castelli, C.F.), University of Verona, Italy.
- Department of Biotechnology (A.G., R.P.R., F. Baldessari), University of Verona, Italy.
- Department of Diagnostics and Public Health, Unit of Forensic Medicine (F. Taus, R.G., F. Bortolotti, F. Tagliaro), University of Verona, Italy.
- Department of Advanced Biomedical Sciences, University Federico II of Naples, Italy (G.G.).
- Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy (F.G.).
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland (A.L., M.V.).
ORCID-Profile: Pietro Minuz, Alessandra Meneguzzi, Francesco Taus, Rui P Ribeiro, Filippo Baldessari, Giuseppe Gargiulo, Felice Gragnano, Marco Castelli, Rossella Gottardo, Federica Bortolotti, Giuseppe Verlato, Cristiano Fava, Marco Cattaneo, Franco Tagliaro, Marco Valgimigli
Zitieren
APA
Minuz, P., Giorgetti, A., Meneguzzi, A., Taus, F., Ribeiro, R. P., Baldessari, F., Gargiulo, G., Gragnano, F., Landi, A., Castelli, M., Gottardo, R., Bortolotti, F., Verlato, G., Fava, C., Cattaneo, M., Tagliaro, F., & Valgimigli, M. (2025). Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(5), 792-804. https://doi.org/10.1161/atvbaha.124.321916
Vancouver
Minuz P, Giorgetti A, Meneguzzi A, Taus F, Ribeiro RP, Baldessari F, et al. Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(5):792-804. doi:10.1161/atvbaha.124.321916
BibTeX
@article{Minuz2025,
author = {Minuz, Pietro and Giorgetti, Alejandro and Meneguzzi, Alessandra and Taus, Francesco and Ribeiro, Rui P and Baldessari, Filippo and Gargiulo, Giuseppe and Gragnano, Felice and Landi, Antonio and Castelli, Marco and Gottardo, Rossella and Bortolotti, Federica and Verlato, Giuseppe and Fava, Cristiano and Cattaneo, Marco and Tagliaro, Franco and Valgimigli, Marco},
title = {Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
volume = {45},
number = {5},
pages = {792--804},
doi = {10.1161/atvbaha.124.321916}
}
EUVIMED